Velorum Therapeutics
Breakthrough medicines unlocking the biology of heme
Operating in healthcare based in San Francisco, CA, USA, Velorum Therapeutics was founded in 2023.
Profile
Velorum Therapeutics is developing breakthrough medicines by unlocking the biology of heme.
Its activity falls under healthcare; the profile below is assembled from public directory data.
Its base of operations is San Francisco, CA, USA.
Directory data places it at the Winter 2024 stage.
Recorded headcount: 5 employees.
Public records show total funding of about $5K.
Directory analysis
Velorum Therapeutics is a U.S. healthcare startup founded in 2023 and headquartered in San Francisco, CA. The company focuses on developing breakthrough medicines by unlocking the biology of heme, a niche area within hematology and metabolic disease research. With a team of five employees and $500 k in funding, it is in the early‑stage development phase.
Positioning: As a Winter 2024 early‑stage biotech, Velorum’s small size and limited capital indicate a nascent pipeline with no commercial products yet. Its focus on heme biology positions it as a potential niche innovator, but it faces typical early‑stage challenges of discovery and validation.
Note: Velorum Therapeutics is a heme‑focused biotech startup in San Francisco.
Auto-generated directory analysis from public data · updated 10 Oct 2026. Informational only, not investment advice.
| Sector | Healthcare |
|---|---|
| Headquarters | San Francisco, CA, USA |
| Country | USA |
| Founded | 2023 |
| Employees | 5 |
| Stage | Winter 2024 |
| Total funding | $500,000 |
Website: www.velorumtx.com
Browse related
Create a free account